Demand for One of the World’s Rarest Assets Is Set to Boom
In 1789, Thomas Jefferson departed France for the United States, on board a boat housing a secret investment.
It was an extremely rare commodity. One that’s been desired for thousands of years. Read on...
Forget what the AMA, the AARP and the SSA have to say about what old people can and can’t do. Instead, listen to legendary pitcher Satchel Paige.
Melanoma is on the rise. So is sunscreen use. Coincidence?
Turns out your body actually makes a couple…
Water. Everyone's thinking about it. Everyone's drinking it. But what's in it, really? And how do you make sure yours is clean? Chris Campbell investigates...
A Note From The Club Director
Kleptocracy (n.) — a government or state in which those in power exploit national resources and steal; rule by a thief or thieves.
For the past five years, 605 of the most influential Fortune 500 CEOs, VPs, and lobbyists have been secretly crafting a massive international trade deal on behalf of the U. Read on...
Check you fridge for these recalled products.
Exactly how to get this powerful hydrogen-rich water
The FDA has banned trans fats. But is that really a good thing?
Can this kind of water make you younger?
To get free, unlimited access to these books and 100s more, join the Laissez Faire Book Club.Of Trade
by David Hume
Release Date: July 9, 2015
David Hume was a famous Scottish philosopher of the 18th century and one of the great defenders of free international trade. Read on...
Millions of people are diagnosed with hypothyroidism each year. And most of them have to take medication for years, if not the rest of their life. But there is a simple mineral deficiency that mimics a lot of the symptoms of hypothyroidism. It’s a lot easier to correct, and you won’t need to take medication if that’s actually what’s causing your hypothyroidism symptoms.
You all wrote in with some great tips and recommendations for water filtration. In fact, the inbox is overflowing.
Could free radicals be like a zombie apocalypse for your body?
There's a mental health crisis occurring in America. And the cures are in the least expected of places: psychedelics. Chris Campbell investigates...
There’s something in your water that could be harming your health
How we spot the lies about supplements
Chances are good this “medicine” is in your home right now. Here’s why you should never use it again.
Just how messed up is our medical system? You won’t believe how many people die from FDA-approved drugs.
I have mad love for doctors…within a certain context. If an infection is involved or surgery must be performed, fine. But if they start telling me to eat a low-fat diet with plenty of grains for my health, or there’s nothing wrong with artificial sweeteners, the best they’re going to get from me is a barely-polite nod.
One of them might be a threat, and the other is a complete fraud…
How many of your fellow readers would already take testosterone? The results might surprise you…
If you take a statin you absolutely must make sure you have adequate levels of this vitamin.
It may be one of the biggest modern health trends, as thousands of men jump on the bandwagon
Are certain foods causing your joint pain? Here’s an easy way to find out.
The TPP, if made into law, could affect nearly every aspect of your day-to-day life. This includes a huge hit on your freedom of speech, and your ability to receive cost-effective healthcare. Read on…
How my mother inspires me to be healthier, and what she’s doing to feel 20 years younger without traditional exercise
How lifting weights can go wrong, and cause your body more damage than health.
Every time you buy a drug at a pharmacy — be it by prescription or over the counter — there’s a middleman that makes a huge profit…
And it doesn’t matter what pharmacy you go to, either. It could be Walgreens, Rite Aid or part of a larger, more integrated health care network… Regardless, the middleman, called a pharmacy benefit manager (or “PBM”), is there taking his cut.
While most PBMs are privately held firms (such as Benecard Services, Innoviant Inc. or WellDyne Inc.), some are publically traded… they could turn out to be the safest way to make money in America over the coming years…
If you haven’t heard of this industry, you may be surprised to find out how tied in it is with individuals and companies — big and small. They are the hustlers of the U.S. healthcare system.
According to BusinessWeek:
“America’s pharmacy benefit managers (PBMs) administer prescription drug benefits for more than 210 million Americans, whose health coverage is provided by Fortune 500 employers, health insurers, labor unions and Medicare Part D.”
Here’s how these companies make their money…
Whenever you go to the pharmacy, you take a special card in order to get your prescription filled. That card, depending on your company’s health benefit package, grants you access to your medication.
The pharmacist checks out your card, figures out which pills your package covers and — under pharmacy guidelines — determines which pill to offer you at what price.
What you’re not told is that the PBM, contracted by companies or health insurers to manage the pharmacy benefits of your health plan, makes all the decisions.
And their decisions are guided by one goal: They want to keep your company’s or health insurer’s spending on pharmaceuticals low.
The best way to do that — and the best way for them to make money themselves — is simple: They issue cheaper generic drugs to you.
Most people tend to be brainwashed by superficial brand loyalty, when they could be getting the exact same thing generically for a huge discount.
Take the example of a cholesterol-lowering drug. It’s basically the same case. You’ll be asked if you want to pay $30 and get a generic cholesterol-lowering pill or you could pay $200 to get something like Lipitor.
Again, generic drugs are tested, and for most people, they provide the same benefit. So unless your doctor insists on the specific brand, you’re going to choose generic.
PBMs love generics because they can aggregate the demand for various cholesterol-lowering drugs based on all the contracts they have with their clients. Then they buy generics in bulk at dirt-cheap prices, mark them up 20-50% and resell them to you.
This is actually a win-win scenario. And if you’re invested in a PBM, it’s a win-win-win scenario. Here’s why…
First, the PBM is saving your company money through lower pharmaceutical spending. Second, your copay is much cheaper than if you were forced to buy the branded pill. And third, the PBM makes a nice profit for itself and its shareholders by reselling the generic drug to customers.
Any PBM that’s looking to increase the number of generics that its customers use translates to higher profits.
Now, let’s review this in the context of tomorrow’s trends…
There are fewer generic drugs coming over the next two years. Last year, for example, according to The New York Times:
“More than 40 brand-name drugs — valued at $35 billion in annual sales — lost their patent protection, meaning that generic companies were permitted to make their own lower-priced versions of well-known drugs…”
But next year…
“the value of drugs scheduled to lose their patents and be sold as generics is expected to decline by more than half, to about $17 billion, according to an analysis by Credit Agricole Securities. ‘The patent cliff is over,’ said Kim Vukhac, an analyst for Credit Agricole. ‘That’s great for large pharma, but that also means the opportunities theoretically have dried up for generics.'”
That’s good news for large generics company Watson Pharmaceuticals, which just merged with and is renamed Actavis…launching it from the fifth to the third-largest generic drugmaker worldwide.
Any PBMs that can claim a large share in the shrinking generics supply could do very well.
Other PBM’s, like the company Actavis, could do very well by developing biosimilars, or generic biotech drugs. Biotech drugs are more expensive than pharmaceuticals. That means that generic biotech drugs have the potential to be more profitable than generic pharmaceuticals. The first of these new drugs will be showing up soon.
Teva Pharmaceuticals, which formed a partnership with Swiss company Lonza, is another example of a company on the road to develop biosimilars.
Two other big reasons these PBMs could become cash cows… If you’re an avid Tomorrow in Review reader, you know about them already: Obamacare and baby boomers.
Obamacare is going to bring another 38 million-some people into the health care system. Many will start using prescription drugs, and they’ll be put on generics through a PBM.
Plus, 76 million-some baby boomers are going to become senior citizens in the next 20 years. They’ll use more prescription drugs as they get older. Lots of generics are going to be used by baby boomers.
For more publically traded PBMs, you can check out the three largest: Caremark (NYSE: CVS), and Express Scripts (NASDAW: ESRX), and Catamaran Corp. (NASDAQ: CTRX).
Article originally appeared here.